Zoetis

Zoetis to Host Webcast and Conference Call on First Quarter 2024 Financial Results

Retrieved on: 
Thursday, March 28, 2024
Agriculture, Natural Resources, Health, Veterinary, Pharmaceutical, Zoetis, Webcast, Inc.

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 2, 2024.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, May 2, 2024.
  • Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review first quarter 2024 financial results and respond to questions from financial analysts during the call.
  • Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations .
  • A replay of the webcast will be made available on May 2, 2024.

Zoetis to Participate in the Barclays Global Healthcare Conference

Retrieved on: 
Tuesday, March 5, 2024
Biotechnology, Pharmaceutical, Health, Veterinary, Inc., Zoetis, Conference

Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) will participate in the Barclays Global Healthcare Conference on Thursday, March 14, 2024.
  • Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts.
  • Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations .
  • A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

Zoetis to Participate in the Bank of America Securities 2024 Animal Health Summit

Retrieved on: 
Wednesday, February 21, 2024
Biotechnology, Pharmaceutical, Health, Veterinary, Bank, Inc., Zoetis

Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2024 Animal Health Summit on Thursday, February 29, 2024.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2024 Animal Health Summit on Thursday, February 29, 2024.
  • Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts.
  • Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations .
  • A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Thursday, December 28, 2023
Agriculture, Natural Resources, Health, Veterinary, Pharmaceutical, Webcast, Inc., Zoetis

(NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 13, 2024.

Key Points: 
  • (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Tuesday, Feb. 13, 2024.
  • Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial Officer Wetteny Joseph will review fourth quarter and full year 2023 financial results and respond to questions from financial analysts during the call.
  • Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations .
  • A replay of the webcast will be made available on Feb. 13, 2024.

Zoetis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Thursday, December 21, 2023
Health, Consumer, Agriculture, Pets, Natural Resources, Veterinary, Conference, Zoetis, Inc.

Zoetis Inc. (NYSE:ZTS) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024.
  • Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts.
  • Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations .
  • A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

Zoetis Declares First Quarter 2024 Dividend; Board Approves 15% Payment Increase

Retrieved on: 
Thursday, December 7, 2023
Other Health, Health, Fitness & Nutrition, Veterinary, Medical Supplies, NYSE, Zoetis, Holding company, Management

As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide -- from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.1 billion in 2022 with approximately 13,800 employees. For more information, visit www.zoetis.com.

Key Points: 
  • The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the first quarter of 2024, an increase of 15% from the quarterly dividend rate paid in 2023.
  • The dividend will be paid on Friday, March 1, 2024, to all holders of record of the Company’s common stock as of the close of business on Friday, January 19, 2024.
  • “Zoetis has continued to perform well this year thanks to our diverse and innovative product portfolio,” said Wetteny Joseph, Executive Vice President and Chief Financial Officer at Zoetis.
  • “I am pleased to announce that we are increasing our dividend in 2024 as part of our commitment to returning excess capital to shareholders.”

Zoetis to Participate in the Piper Sandler 35th Annual Healthcare Conference

Retrieved on: 
Tuesday, November 21, 2023
Health, Consumer, Agriculture, Pets, Natural Resources, Veterinary, NYSE, Conference, Inc., Piper Sandler Companies, Zoetis, Pharmaceutical industry, Online shopping

Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023.
  • Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts.
  • Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations .
  • A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

Specialty Sales Names Matthew Nelson as CEO

Retrieved on: 
Monday, November 6, 2023
Veterinary, Agriculture, Natural Resources, Finance, Health, Chemicals, Plastics, Professional Services, Manufacturing, Boehringer Ingelheim, Sales, Pig, Food, Zoetis, Poultry, Farmer, Animal, National Dairy Development Board, Culture, Marketing, Boehringer Ingelheim Animal Health, Dairy

“Hoofstrong”), the leading provider of hoof health solutions to the U.S. dairy industry, today announced the appointment of Matthew Nelson as CEO.

Key Points: 
  • “Hoofstrong”), the leading provider of hoof health solutions to the U.S. dairy industry, today announced the appointment of Matthew Nelson as CEO.
  • Specialty Sales is a portfolio company of Kainos Capital, a consumer-focused private equity firm that invests in strategically relevant growth companies in the food, pet, animal health, specialty distribution and services industries.
  • Mr. Alsup said, “We are pleased to welcome Matt to Specialty Sales.
  • Matt is uniquely qualified to lead Specialty Sales given his professional background that spans animal health and nutrition across bovine, poultry, swine, equine and companion animals.

Zoetis Announces Third Quarter 2023 Results

Retrieved on: 
Thursday, November 2, 2023
Veterinary, Biotechnology, Pharmaceutical, General Health, Health, Fitness & Nutrition, Clinical Trials, Other Health, Growth, Inc., NYSE, International, Cattle, Pig, Vaccine, Dermatology, Poultry, Cat, Prevalence, Livestock, Acquisition, Webcast, Animal, Pain management, Dog, MFA Oil, Video game, Cryptocurrency, Otodectes, Sarolaner, Zoetis, Frunevetmab

(NYSE: ZTS) today reported its financial results for the third quarter of 2023 and updated its guidance for full year 2023.

Key Points: 
  • (NYSE: ZTS) today reported its financial results for the third quarter of 2023 and updated its guidance for full year 2023.
  • The company reported revenue of $2.2 billion for the third quarter of 2023, an increase of 7% compared with the third quarter of 2022.
  • On an operational1 basis, revenue for the third quarter of 2023 increased 8% compared with the third quarter of 2022, excluding the impact of foreign currency.
  • Zoetis will host a webcast and conference call at 8:30 a.m. (ET) today, during which company executives will review third quarter 2023 results, discuss financial guidance and respond to questions from financial analysts.

Zoetis Named a 100 Best Company for Working Parents by Seramount

Retrieved on: 
Tuesday, October 10, 2023
Other Health, Consumer, Health, Pets, Veterinary, Partnership, Family, Student, Culture, Animal, Private practice, Metabolism, Parenting, Dog, Parent, Ehlers–Danlos syndromes, Management, Nursing, Zoetis, Safety

Dr. Kevin Esch Named Zoetis’ Working Father of the Year
Zoetis named Dr. Kevin Esch, D.V.M., M.P.H., Ph.D., Dipl. ACVP, its 2023 Working Father of the Year. After working as a veterinarian in private practice for several years, Kevin joined Zoetis in 2014 as a pathologist in Veterinary Medical Research and Development. Since then, he has held various leadership roles, most currently as Executive Director of Global Pharmacokinetics, Dynamics, Metabolism and Safety. A father to daughters, Gabriella, 18, Eva, 16 and Vivienne, 11, two of Kevin’s children have Ehlers Danlos Syndrome, a spectrum of chronic connective tissue disorders that requires an endless schedule of appointments in addition to an already busy schedule. “It would be impossible to manage a career and family without a true partnership with my wife Staci, whose sacrifices and coordination in managing these medical challenges is amazing,” said Kevin. Kevin also believes that his parenting experience has made him a more empathetic leader. “As leaders, we can all continue to improve our ability to meet our colleagues where they are -- in their roles, at a stage in a project, or on a particular day. More than anything, my experience parenting has helped me gain an understanding, at work and at home, of how to determine what is truly important, and where I should focus my energy,” he said. Learn more about Kevin here.

Key Points: 
  • For the tenth year in a row, Zoetis , the world leader in animal health, has been named one of Seramount’s 100 Best Companies for Working Parents.
  • The recognition reflects Zoetis’ commitment to providing a culture focused on colleagues’ careers, connection and support.
  • We are honored to once again be named one of Seramount’s 100 Best Companies for Working Parents.”
    As part of the 100 Best Companies recognition, Zoetis named Mary Bradley its 2023 Working Mother of the Year.
  • After working as a veterinarian in private practice for several years, Kevin joined Zoetis in 2014 as a pathologist in Veterinary Medical Research and Development.